Takeda Pharmaceutical
TAK
#457
Rank
HK$422.04 B
Marketcap
HK$133.59
Share price
-2.79%
Change (1 day)
15.33%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): HK$26.00 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are HK$29.86 Billion. , an increase over its 2024 earnings that were of HK$17.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 HK$26.04 B49.03%
2024 HK$17.47 B-2.41%
2023 HK$17.90 B-28.14%
2022 HK$24.91 B-40.9%
2021 HK$42.16 B78.24%
2020 HK$23.65 B246.1%
2019 HK$6.83 B-48.79%
2018 HK$13.34 B-23.64%
2017 HK$17.47 B21.7%
2016 HK$14.35 B-253.01%
2015 -HK$9.39 Billion-159.65%
2014 HK$15.73 B13%
2013 HK$13.92 B2.46%
2012 HK$13.58 B-57.05%
2011 HK$31.63 B-10.49%
2010 HK$35.34 B-3.99%
2009 HK$36.80 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$262.73 B 908.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$128.04 B 391.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$79.81 B 206.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$70.28 B 169.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$60.29 B 131.51%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$175.59 B 574.24%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$77.49 B 197.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-HK$6.2 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$6.83 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India